Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

GeoVax Labs (GOVX) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for GeoVax Labs (GOVX) over the last 15 years, with Q2 2025 value amounting to 635.81%.

  • GeoVax Labs' EBITDA Margin rose 10478000.0% to 635.81% in Q2 2025 from the same period last year, while for Sep 2025 it was 761.63%, marking a year-over-year increase of 310000.0%. This contributed to the annual value of 635.83% for FY2024, which is N/A changed from last year.
  • Per GeoVax Labs' latest filing, its EBITDA Margin stood at 635.81% for Q2 2025, which was up 10478000.0% from 330.22% recorded in Q1 2025.
  • GeoVax Labs' 5-year EBITDA Margin high stood at 209.88% for Q3 2024, and its period low was 8331.46% during Q4 2021.
  • In the last 4 years, GeoVax Labs' EBITDA Margin had a median value of 1550.06% in 2021 and averaged 2483.22%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -78000700bps in 2021, then skyrocketed by 10478000bps in 2025.
  • Over the past 4 years, GeoVax Labs' EBITDA Margin (Quarter) stood at 8331.46% in 2021, then soared by 64bps to 2978.24% in 2022, then skyrocketed by 68bps to 965.32% in 2024, then surged by 34bps to 635.81% in 2025.
  • Its EBITDA Margin stands at 635.81% for Q2 2025, versus 330.22% for Q1 2025 and 965.32% for Q4 2024.